|
|
|
(13.58.121.214)
|
|
Users online: 9561
|
|
|
|
|
|
|
Ijournet
|
|
|
|
|
|
|
Risk analysis evaluation of piroxicam 20mg capsules manufacture process by fmea technique Priscila Cardoso*, Flávia Marotta, Kelen Siqueira Pharmascience Indústria Farmacêutica, Minas Gerais, Brazil *Corresponding Author's E-mail: cardosopriscila18@gmail.com
Online published on 17 September, 2019. Abstract This paper presents an application of FMEA (Failure Mode and Effects Analysis) on the manufacturing process of Piroxicam 20mg capsules, with the objective of identifying possible failures and creates subsidies for improvement of the production stages. Brainstorming or Collaborative critical analysis was used as a tool to collect information and support FMEA's application. After the risk analysis, evaluation of the production process using FMEA, manipulation and secondary packaging were found to be the critical stages in the production process necessary for implementation of actions in order to mitigate the risks. Top Keywords Risk analysis, FMEA, Piroxicam, manufacture process. Top | |
|
|
|
|
║ Site map
║
Privacy Policy ║ Copyright ║ Terms & Conditions ║
|
|
|
748,348,459 visitor(s) since 30th May, 2005.
|
|
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
|
|
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.
|